Search results for: 'biological particip analysis'

Radical changes in science and technology are helping the human body evolve. Biological augmentations and body enhancements are transforming the human body and bringing about a kind of transhumanism by eliminating diseases, extending life spans, and enhancing human capabilities. Biological augmentations and body enhancements are classified into th...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

19 Sep 2018  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

Infographics

×

Key Issues Addressed

The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...

This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredients mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthet...

Next-generation fermentation pathways for sustainable fuel production represent an evolving suite of biological and bio-electrochemical processes designed to convert diverse carbon sources, such as CO₂, biomass, waste gases, and organic residues, into liquid fuels. These approaches integrate advances in metabolic engineering, synthetic biology, and...